Stock Price Forecast

Dec. 8, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Akoya Biosciences Inc chart...

About the Company

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Exchange

NASDAQ

Website

www.akoyabio.com

$69M

Total Revenue

169

Employees

$468M

Market Capitalization

-6.92

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AKYA News

Institutions own 23% of Akoya Biosciences, Inc. (NASDAQ:AKYA) shares but private equity firms control 49% of the company

2d ago, source:

A look at the shareholders of Akoya Biosciences, Inc. ( NASDAQ:AKYA ) can tell us which group is most powerful. We ...

Akoya Biosciences, Inc. (AKYA) Q3 2022 Earnings Call Transcript

1mon ago, source: Seeking Alpha

Good day and thank you for standing by. Welcome to the Akoya Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Akoya Biosciences Inc. (NASDAQ: AKYA) Up 4.42%: This Is What Analysts Are Now Forecasting

7d ago, source:

Akoya Biosciences Inc. (NASDAQ:AKYA) price on Wednesday, November 30, rose 4.42% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $12.98. A look at the ...

Akoya Biosciences Inc.

24d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance

1mon ago, source: Yahoo! Sports

MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its ...

Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy

1mon ago, source: Yahoo! Sports

Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the launch of PhenoCode™ Signature Panels for high-throughput spatial ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...